NVDA is my first buy in close to a month after being stopped out of everything at the beginning of the month. I bought a quarter position in the morning, followed by another quarter later in the day, bringing me to a half sized position at an average price of $238.86. Not in any hurry to add size until I get some traction with the shares I have. The green light...
$TRGP in midst of a setup (cup and handle) within its uptrend line supporting since jan'21. do note bigger cap oil & gas names (eg. $CNQ, $CVE, $DVN, $PXD) have earlier ran much ahead of their 52wks high in early January. earnings on 24th feb pre-market
$BABA is caught in a 15-month downtrend channel but there could be short term upside opportunity ahead. trading above Q2 earnings VWAP & 10/20MA. also attempted to re-capture its 50MA, with MA convergences taking place. price action behavior is very similar to oct'21 period.
$METC based out from dec'21 and continues riding up its 20MA within a tight channel, also trading beyond its VWAP from ATH. ADR now is at 5.65% to price, and uptick in daily volume for 4 consecutive session. this is the kind of behavior that may set for a parabolic move imho
$SWAV remains supported at $165 since early dec'21 when market experiences 2 period of weaknesses. not the strongest name for past months but could be poised to be a late runner. have been challenging VWAP from ATH since 2022. recaptured its 10week MA this week.
$SNOW setup for a mean reversion swing on its hammer candlestick pattern, sitting on its rising 200MA. a reversal from this juncture would paint out a cup and handle pattern on its weekly YoY Q3 EPS +113% Q3 Sales +110%
$SRTS cleared a one year base cleanly with a high tight flag consolidation right now. breakout level at $8.55 will be 52 weeks high. YoY Q3 EPS + 110% Q3 Sales + 241%
$FXLV broke above its VWAP anchored from a high established prior to Q3 earnings sell down. 1-month RS. higher lows in price action, trading above a potential rising 10 and 20MA. daily price range remains volatile at 6.49% to price. $11.85 would clear 3 weeks high
$PRTA late stage biotech firm. have higher low tightening price action since mid dec, closing above 10/20 and 200MA for the first time after a ATH peak to trough correction of -38% 3 months ago. lucrative risk reward if this trades work
MRVL had a strong earnings gap back in early December, has consolidated and held onto the gains since. The company is showing strong earnings growth QoQ and YoY and is in a strong industry. Bought shares as the stock appears to be coming out of a volatility contraction period and may be beginning a post-earnings drift higher.
The Market's longer term uptrend still intact and things look cautiously optimistic. These names have shown good relative strength and accumulation volume and most are in the growth sector. This may give good risk/reward entries on some of the best names. Some of these charts still need to confirm their price action. This video is my watchlist. Most of these names...
$SUM reflected intraday RS, wriggling out of its downtrend line. it is one of the few names with a price action supported on its rising 50MA during the December market weakness.
The Market's longer term uptrend still intact and things look cautiously optimistic. These names have shown good relative strength and accumulation volume and most are in the growth sector. This may give good risk/reward entries on some of the best names. Some of these charts still need to confirm their price action. This video is my watchlist. Most of these names...
The Market's longer term uptrend still intact but short term looks precarious. These names have shown good relative strength and accumulation volume and most are in the growth sector. This may give good risk/reward entries on some of the best names. Some of these charts still need to confirm their price action. This video is my watchlist. Most of these names are...
Here is the link for our updated watchlist. www.tradingview.com All stocks on this list are meeting IBD's CAN SLIM- and Mark Minervini's SEPA selection criteria. Only a short list for now - this also represents the difficult environment we are currently in - very frothy, high volatility, especially for growth stocks - elevated level of caution is advised!
The Market's longer term uptrend still intact. These names have shown good relative strength and accumulation volume and most are in the growth sector. This may give good risk/reward entries on some of the best names. Some of these charts still need to confirm their price action. This video is my watchlist. Most of these names are at or near all time highs or...
Started position as the stock came through its inside pivot & PEG day anchored VWAP. Ran up nicely before giving a lot of the move back in the afternoon. CPRI showed massive growth in EPS last year (+205.52%) and estimates for the current year (with 2 quarters already reported) are EPS growth of 180.87% with sales growth of 33.37% supporting the EPS...
The Market's longer term uptrend still intact. These names have shown good relative strength and accumulation volume and most are in the growth sector. This may give good risk/reward entries on some of the best names. Some of these charts still need to confirm their price action. This video is my watchlist. Most of these names are at or near all time highs or...